Page last updated: 2024-08-25

rosiglitazone and Chronic Kidney Diseases

rosiglitazone has been researched along with Chronic Kidney Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, X; Gu, J; He, T; Huang, Y; Liu, C; Liu, L; Liu, Y; Nie, L; Xiong, J; Xu, X; Yang, K; Yu, Y; Zhang, B; Zhang, J; Zhang, Y; Zhang, Z; Zhao, J1
Czekuć-Kryskiewicz, E; Karczmarewicz, E; Lorenc, RS1
Hu, M; Huang, Y; Lei, Y; Liu, R; Wang, X; Yu, X; Zheng, Z1
Greevy, RA; Griffin, MR; Grijalva, CG; Hung, AM; Ikizler, TA; Liu, X; Murff, HJ; Roumie, CL1
Ahbap, E; Basturk, T; Borlu, F; Koc, Y; Sakaci, T; Ulas, T; Unsal, A1

Reviews

1 review(s) available for rosiglitazone and Chronic Kidney Diseases

ArticleYear
[Pathologies of calcium-phosphate homeostasis].
    Postepy biochemii, 2012, Volume: 58, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Bone and Bones; Calcitriol; Calcium Phosphates; Disease Progression; Fibroblast Growth Factor-23; Homeostasis; Humans; Hyperphosphatemia; Kidney; Parathyroid Glands; Parathyroid Hormone; Renal Insufficiency, Chronic; Renin-Angiotensin System; Rosiglitazone; Thiazolidinediones; Up-Regulation; Vitamin D

2012

Other Studies

4 other study(ies) available for rosiglitazone and Chronic Kidney Diseases

ArticleYear
High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Journal of molecular and cellular cardiology, 2018, Volume: 114

    Topics: Adolescent; Adult; Aged; Animals; Cell Line; Diet; Down-Regulation; Feeding Behavior; Female; Glucuronidase; Humans; Klotho Proteins; Methyl-CpG-Binding Protein 2; Mice; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphates; PPAR gamma; Renal Insufficiency, Chronic; RNA, Small Interfering; Rosiglitazone; Vascular Calcification; Young Adult

2018
Rosiglitazone alleviates injury in rats with adenine‑induced chronic kidney disease.
    Molecular medicine reports, 2013, Volume: 8, Issue:6

    Topics: Adenine; Animals; Creatinine; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Function Tests; Kidney Tubules; Male; Parathyroid Hormone; Phosphates; Proteinuria; Rats; Renal Insufficiency, Chronic; Rosiglitazone; Staining and Labeling; Thiazolidinediones

2013
Comparative effectiveness of incident oral antidiabetic drugs on kidney function.
    Kidney international, 2012, Volume: 81, Issue:7

    Topics: Administration, Oral; Aged; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Hypoglycemic Agents; Kidney; Male; Metformin; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome

2012
Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:11

    Topics: Blood Glucose; Blood Pressure; C-Reactive Protein; Humans; Hypoglycemic Agents; Insulin Resistance; Prospective Studies; Renal Insufficiency, Chronic; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2012